Septic pneumonic tularaemia caused by Francisella tularensis subsp holarctica biovar II

被引:11
作者
Fritzsch, Joerg [1 ]
Splettstoesser, Wolf D. [2 ]
机构
[1] HELIOS Klin Zwenkau, Clin Internal Med, Zwenkau, Germany
[2] Bundeswehr Inst Microbiol, Dept Immunol, German Natl Reference Lab Tularaemia, Munich, Germany
关键词
SEROPREVALENCE; CEFTRIAXONE; GERMANY; STRAINS;
D O I
10.1099/jmm.0.019893-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
This case of pneumonic tularaemia elucidates two aspects: it is believed to be the first documented case of bacteraemia caused by Francisella tularensis subsp. holarctica biovar II; furthermore, it illustrates the remission of septic pneumonic tularaemia without appropriate anti-infective therapy. A blood culture from a patient with community-acquired pneumonia was found to be positive for F. tularensis subsp. holarctica biovar II after 10 days of cultivation. Meanwhile, the patient had been treated with ceftriaxone, followed by sultamicillin and clindamycin. The patient continued suffering from fever of up to 40.7 degrees C and rising C-reactive protein (CRP) for 4 days before the fever and CRP declined. The isolated strain was later tested and found to be resistant to the antibiotics used. The present case underlines that F. tularensis subsp. holarctica infections may cause severe symptoms but mostly have a favourable outcome.
引用
收藏
页码:1123 / 1125
页数:3
相关论文
共 17 条
[1]   ANTIMICROBIAL SUSCEPTIBILITY TESTING OF FRANCISELLA-TULARENSIS WITH A MODIFIED MUELLER-HINTON BROTH [J].
BAKER, CN ;
HOLLIS, DG ;
THORNSBERRY, C .
JOURNAL OF CLINICAL MICROBIOLOGY, 1985, 22 (02) :212-215
[2]   COMPARATIVE PHARMACOKINETICS OF CEFTRIAXONE AFTER SUBCUTANEOUS AND INTRAVENOUS ADMINISTRATION [J].
BORNER, K ;
LODE, H ;
HAMPEL, B ;
PFEUFFER, M ;
KOEPPE, P .
CHEMOTHERAPY, 1985, 31 (04) :237-245
[3]   Genome-wide DNA microarray analysis of Francisella tularensis strains demonstrates extensive genetic conservation within the species but identifies regions that are unique to the highly virulent F-tularensis subsp tularensis [J].
Broekhuijsen, M ;
Larsson, N ;
Johansson, A ;
Byström, M ;
Eriksson, U ;
Larsson, E ;
Prior, RG ;
Sjöstedt, A ;
Titball, RW ;
Forsman, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (07) :2924-2931
[4]   TULAREMIA - TREATMENT FAILURES WITH OUTPATIENT USE OF CEFTRIAXONE [J].
CROSS, JT ;
JACOBS, RF .
CLINICAL INFECTIOUS DISEASES, 1993, 17 (06) :976-980
[5]   Tularaemia in an emergent area in Sweden:: An analysis of 234 cases in five years [J].
Eliasson, Henrik ;
Back, Erik .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2007, 39 (10) :880-889
[6]   Tularemia on Martha's vineyard: Seroprevalence and occupational risk [J].
Feldman, KA ;
Stiles-Enos, D ;
Julian, K ;
Matyas, BT ;
Telford, SR ;
Chu, MC ;
Petersen, LR ;
Hayes, EB .
EMERGING INFECTIOUS DISEASES, 2003, 9 (03) :350-354
[7]   Serologic evidence of human infection by Francisella tularensis in the population of Castilla y Leon (Spain) prior to 1997 [J].
Gutiérrez, MP ;
Bratos, MA ;
Garrote, JI ;
Dueñas, A ;
Almaraz, A ;
Alamo, R ;
Marcos, HR ;
Recio, MJR ;
Muñoz, MF ;
Orduña, A ;
Rodríguez-Torres, A .
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2003, 35 (02) :165-169
[8]   PLEUROPULMONARY TULAREMIA - SUCCESSFUL TREATMENT WITH ERYTHROMYCIN [J].
HARRELL, RE ;
SIMMONS, HF .
SOUTHERN MEDICAL JOURNAL, 1990, 83 (11) :1363-1364
[9]   Investigating an Airborne Tularemia Outbreak, Germany [J].
Hauri, Anja M. ;
Hofstetter, Iris ;
Seibold, Erik ;
Kaysser, Philip ;
Eckert, Juergen ;
Neubauer, Heinrich ;
Splettstoesser, Wolf D. .
EMERGING INFECTIOUS DISEASES, 2010, 16 (02) :238-243
[10]   WATERBORNE AND AIRBORNE FRANCISELLA-TULARENSIS BIOVAR PALAEARCTICA ISOLATED FROM HUMAN BLOOD [J].
HOEL, T ;
SCHEEL, O ;
NORDAHL, SHG ;
SANDVIK, T .
INFECTION, 1991, 19 (05) :348-350